Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-01 Lynch Casey Chief Executive Officer Sale −371 $39.23 $15K 1,078,774
2020-12-14 Holsinger Leslie Executive Vice President Option exercise +40,000 $0.27 $11K 43,500
2020-12-14 Holsinger Leslie Executive Vice President Sale −1,700 $28.80 $49K 41,800
2020-12-14 Holsinger Leslie Executive Vice President Sale −14,275 $30.15 $430K 27,525
2020-12-14 Holsinger Leslie Executive Vice President Sale −13,200 $30.91 $408K 14,325
2020-12-14 Holsinger Leslie Executive Vice President Sale −9,525 $31.79 $303K 1,800
2020-12-14 Holsinger Leslie Executive Vice President Sale −400 $32.59 $13K 4,400
2020-12-14 Holsinger Leslie Executive Vice President Sale −900 $32.59 $29K 3,500
2020-12-14 Holsinger Leslie Executive Vice President Option exercise · Stock Option (Right to Buy) −40,000 66,794
2020-12-11 Holsinger Leslie Executive Vice President Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Holsinger Leslie Executive Vice President Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Lynch Casey Chief Executive Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2020-12-11 Lynch Casey Chief Executive Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2020-12-11 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Dominy Stephen S. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Dominy Stephen S. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 LOWE CHRISTOPHER P. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 LOWE CHRISTOPHER P. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 McDowell Caryn Gordon Chief Legal & Adm. Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 13 of 18 · 350 trades